Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Sickle Cell Disease, Beta Thalassemia Intermedia
Interventions
DIAGNOSTIC_TEST

RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR

"Quantatative Real -Time PCR for quantification of PUM1;~* The type of the recruited samples: Ethylenediamine tetra-acetic acid (EDTA) peripheral blood samples.~* The method of total RNA extraction: TRIzol and TRIzol LS.~* The purity and concentration of the RNA were measured using a Nano Drop 2000 instrument.~* cDNA was amplified with primers using the GoScript Reverse Transcription system.~Western Blotting Assay of PUM1 protein levels"

All Listed Sponsors
lead

Assiut University

OTHER

NCT05883254 - Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia | Biotech Hunter | Biotech Hunter